IMMUNEONCO-B (01541) Subscribes to HK$120 Million Wealth Management Product

Stock News11-20

IMMUNEONCO-B (01541) announced that on November 20, 2025, the company notified Huatai Financial to redeem HK$49.6033 million (first redemption) and HK$43.72 million (second redemption) of Huatai redemption products, representing its full holdings at the time. The estimated gains were approximately HK$3.46 million and HK$1.27 million, respectively (collectively referred to as the redemption transactions, reflecting unaudited interest income). Following these redemptions, the group no longer holds any outstanding wealth management products from Huatai Financial. Additionally, on November 20, 2025, the company agreed to subscribe to a HK$120 million wealth management product (Huatai subscription product) from Huatai Financial (the subscription transaction). The subscription was funded by the group's internal surplus cash reserves.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment